Virmedex Launches Dex: The First Perfusion AI Chatbot

BARCELONA, Spain - April 11, 2024 - PRLog -- Virmedex, an emerging innovator in medical simulation training, has announced the introduction of Dex, the first All-things Perfusion AI Chatbot. This groundbreaking development marks a significant advancement in training technology, demonstrating Virmedex's commitment to revolutionizing the field of healthcare education worldwide.

"We are thrilled to introduce Dex to our users," says Dr. Martí de Castro, AI Chief of Virmedex. Dex will be available to all Virmedex platform users at no additional cost, providing invaluable assistance with complex perfusion-related calculations, board exam preparation, theoretical concepts, and more. For those interested in using Dex exclusively, it will be available for a nominal fee. "The launch of our Dex represents a significant milestone for our company, marking the successful integration of cutting-edge technology as a cornerstone of our operations. This advancement has the potential to contribute significantly to perfusion in the medical industry" concludes Dr. de Castro.

Following the introduction of Dex, Virmedex is proud to announce the relaunch of its groundbreaking virtual training cardiopulmonary video game, virCPB. This exciting development builds upon the success of the initial launch in 2023. "We are very pleased with this relaunch of virCPB," says Núria Bonet, COO, and co-founder of Virmedex. "Now, users will experience training with a modernized pump, state-of-the-art monitors, and an environment that closely mirrors advanced technologies available in the market. The reception of virCPB in its first year has been fantastic, and we are excited to continue improving the platform with new features such as analytics, comprehensive pump operation, and enhanced training activities."

Moreover, the new virCPB is also compatible with VR technology, offering users an unparalleled immersive experience akin to a real operating room. Since its initial launch, virCPB has gained popularity among perfusion schools worldwide, thanks to its innovative and affordable subscription model for individuals and institutions. The relaunch of virCPB represents a major achievement for Virmedex, further solidifying its position as an emerging leader in medical simulation training.

Virmedex, is a Barcelona (Spain)- based startup with a global reach, emerged as a spin-off from the Technical University of Catalonia and the University of Barcelona. Its technology has been developed in close collaboration with the Clinical Hospital of Barcelona.

Visit Virmedex at http://www.virmedex.com